IP Library Patent Application 17317374
Patent Application
App. No. 17/317,374

DEVICES AND METHODS FOR PROVIDING HYDROLYZED LIPIDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/317,374
Abstract

Exemplary embodiments of the disclosure may be drawn to a device having a vessel configured to contain a source of lipids and a chamber fluidly connected to an outlet of the vessel. The chamber may contain immobilized lipase positioned within a flow path in the chamber along which the lipids flow when released from the vessel into the chamber. The device may also include an outlet through which the lipids flow after passing through the chamber.

Claims (40)

1 - 23 . (canceled)

24 . A device comprising:

a vessel configured to store a flowable lipid;

a chamber including an inlet and an outlet, wherein the chamber is connected to an opening of the vessel, and wherein the chamber contains lipase; and

one of an interface or an output assembly coupled to the chamber, wherein a flow path extends through an opening in the vessel, through the inlet of the chamber, through the outlet of the chamber, and through the interface or the output assembly;

wherein at least one of an outlet of the interface or the outlet assembly or the opening of the vessel is configured to retain the flowable lipid within the vessel prior to use of the device.

25 . The device of claim 24 , wherein the vessel contains the flowable lipid.

26 . The device of claim 25 , wherein the flowable lipid includes at least one of an oil, an infant fortifier, docosahexaenoic acid, or arachidonic acid.

27 . The device of claim 24 , wherein the vessel is removably coupled to the chamber.

28 . The device of claim 24 , wherein the vessel is prefilled.

29 . The device of claim 24 , wherein the vessel is refillable.

30 . The device of claim 24 , wherein the flowable lipid is stored under pressure in the vessel.

31 . The device of claim 24 , wherein the vessel is compressible.

32 . The device of claim 31 , further comprising a compression roller configured to compress the vessel.

33 . The device of claim 24 , wherein the chamber comprises a clear or opaque material.

34 . The device of claim 24 , wherein the vessel is removably coupled to the chamber.

35 . The device of claim 34 , wherein at least one of the outlet of the interface or the outlet assembly or the opening of the vessel is sealed prior to use of the device.

36 . The device of claim 24 , further comprising a valve fluidly coupled to the vessel.

37 . The device of claim 24 , further comprising a filter coupled to the chamber.

38 . A device comprising:

a vessel configured to store a flowable lipid;

a chamber including an inlet and an outlet, wherein the chamber is connected to an opening of the vessel, and wherein the chamber contains lipase;

an interface coupled to the chamber, wherein a flow path extends through an opening in the vessel, through the inlet of the chamber, through the outlet of the chamber, and through the interface; and

a connector fluidly coupled to an outlet of the interface, wherein the connector includes:

a first opening;

a second opening; and

a connector flow path extending through the connector from the first opening to the second opening.

39 . The device of claim 38 , wherein the first opening of the connector and the second opening of the connector are each configured to fluidly couple to a feeding tube.

40 . The device of claim 38 , wherein the connector is shaped as a hollow tube, and wherein the outlet of the interface is fluidly connected to a central region of the connector.

41 . The device of claim 38 , wherein the flowable lipid includes two or more different types of lipids.

42 . The device of claim 38 , wherein the vessel is compressible.

43 . The device of claim 38 , wherein the opening of the vessel is configured to transition from a first configuration in which the flowable lipid is retained within the vessel, and a second configuration in which the flowable lipid is permitted to flow out of the opening of the vessel in response to an application of pressure to at least a portion of the vessel.

44 . A method of adding hydrolyzed lipids to a liquid prior to ingestion, the method comprising:

causing a source of flowable lipid stored in a vessel of a device to flow out of the vessel and through a chamber of the device that contains lipase in order to hydrolyze the flowable lipid by exposing the flowable lipid to the lipase in the chamber; and

outputting the hydrolyzed lipids from the chamber of the device into the liquid prior to ingestion of the liquid.

45 . The method of claim 44 , further comprising filing the vessel with the source of flowable lipid prior to causing the flowable lipid to flow through the chamber.

46 . The method of claim 44 , further comprising attaching the device to a feeding system prior to passing the flowable lipid through the chamber.

47 . The method of claim 46 , wherein the feeding system is a syringe or container holding a nutritional formula.

48 . The method of claim 44 , further comprising detaching the vessel from the device, refilling the vessel with the source of flowable lipid, and reattaching the vessel to the device.

49 . The method of claim 44 , wherein the flowable lipid includes two or more different types of lipids.

Assignments (4)
SECURITY INTEREST Recorded Mar 12, 2024
From: ALCRESTA THERAPEUTICS, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 066742/0319 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT (PATENTS) AT REEL/FRAME: 058415/0114 Recorded Mar 12, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ALCRESTA THERAPEUTICS, INC.
Reel/Frame 066799/0356 →
SECURITY INTEREST Recorded Dec 17, 2021
From: ALCRESTA THERAPEUTICS, INC.
To: SILICON VALLEY BANK
Reel/Frame 058415/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2021
From: FIRST, ERIC; WIDOM, DAVID
To: ALCRESTA THERAPEUTICS, INC.
Reel/Frame 056506/0615 →